eXoZymes

EXOZ · NASDAQ

$4.12+$0.12 (+3.00%)TodayMarket closed · Oct 20, 5:39 PM ET

Prev close $4.00

About EXOZ

eXoZymes, Inc. is a development stage synthetic biochemical company. The company is headquartered in Monrovia California, California and currently employs 32 full-time employees. The company went IPO on 2024-11-13. The firm has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.

Employees: 32
Headquarters: Monrovia California, California
Listed: Nov 13, 2024
Sector: Health Care
Industry: Biotechnology
Website: exozymes.com

Leadership

eXoZymes executives
Name	Title	Since	Age
Christopher Marlett	—	2019	60
Michael Heltzen	—	—	44
Fouad Nawaz	—	—	39
Tyler Korman	—	—	46
Paul Opgenorth	—	—	42
Anthony DiGiandomenico	—	—	58
Edgardo Rayo	—	—	38
Lon Bell	—	—	84
James Bowie	—	—	64
James Lalonde	—	—	64
Lasse Goerlitz	—	—	—

Similar companies

Companies in the same industry as eXoZymes

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.